Articles

Quick View: Grail Is Progressing On Clinical Trials For Its Multi Cancer Test But Antitrust Challenges Continue

Medical Devices / United States / Wed 22 Nov, 2023

The Latest: On November 20 2023, Grail announced that it will initiate the Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH) study, which aims to assess the clinical impact of the Galleri multi-cancer early detection (MCED) test among Medicare beneficiaries in the US. This announcement comes after the FDA approved

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.